NCT02060851View on ClinicalTrials.gov

Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Malnutrition
Interventions
OTHER

standard PN

Group 1: a control group who received standard PN

DRUG

Vifor

iron sucrose, 200 μg/kg per day, was given everyday with PN,

DRUG

Vifor and EPO

EPO, 400U/kg, was given twice a week (Monday and Friday). IS, 200 μg/kg per day, was given everyday with PN, and the dose was continued until 2 weeks after birth

Trial Locations (1)

215300

Kunshan First Hospital, Kunshan

All Listed Sponsors
lead

Kunshan First People's Hospital Affiliated to Jiangsu University

INDUSTRY

NCT02060851 - Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants | Biotech Hunter | Biotech Hunter